跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 335,335 条关于
“Apolipoprotein A-I”
全部
335,335
临床试验
284,501
药物
6,035
机构
4,065
资讯
40,734
2年前
ApoA-I Infusions Show Promise in Reducing Cardiovascular Events Post-MI, Especially in Patients with Lower LDL-C
去年
EMA Provides Positive Feedback on ABIONYX Pharma's CER-001 for LCAT Deficiency
4年前
Myocardial Infarction: Promising Therapies Advance Through Clinical Trials
去年
Myocardial Infarction Therapeutics Pipeline Shows Promise with Over 45 Companies Involved
去年
Scribe Therapeutics Demonstrates Breakthrough CRISPR Therapy for Cardiovascular Disease with >90% Lp(a) Reduction
去年
Arrowhead Seeks FDA Approval for Plozasiran in Familial Chylomicronemia Syndrome
去年
Ionis' Tryngolza Approved for FCS as Arrowhead's Plozasiran Awaits FDA Review
10个月前
FDA Approves First siRNA Therapy Plozasiran for Rare Metabolic Disorder Familial Chylomicronemia Syndrome
去年
Plozasiran Shows Promise in Phase III Trial for Familial Chylomicronemia Syndrome
2年前
Arrowhead's Plozasiran Receives FDA Breakthrough Therapy Designation for Familial Chylomicronemia Syndrome
第 1 页,共 4074 页
上一页
下一页